Position in SABS
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$1,462,500
-$69,500 QoQ
Shares Held
375,000
-6.2% QoQ
Ownership
0.412%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#25
of 86 holders
Holding Since
Sep 2025
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in SABS Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AWM Investment Company, Inc. holds $126,778,855 across 25 Biotechnology names. SABS ranks #17 (1.2% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | DFTX |
Definium Therapeutics, Inc.
|
784,800 | $36,916,992 | |
| 2 | FENC |
Fennec Pharmaceuticals Inc.
|
1,160,296 | $12,473,182 | |
| 3 | ACOG |
Alpha Cognition Inc.
|
1,672,168 | $12,073,052 | |
| 4 | PVLA |
Palvella Therapeutics, Inc.
|
69,416 | $10,608,153 | |
| 5 | ABEO |
Abeona Therapeutics Inc.
|
1,486,130 | $9,184,283 | |
| 6 | RANI |
Rani Therapeutics Holdings, Inc.
|
7,500,000 | $5,700,000 | |
| 7 | FBRX |
Forte Biosciences, Inc.
|
222,500 | $4,728,125 | |
| 8 | ELDN |
Eledon Pharmaceuticals, Inc.
|
1,100,000 | $4,334,000 |
All Filings in SABS
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,462,500 | 375,000 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $1,532,000 | 400,000 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $748,000 | 200,000 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $402,000 | 200,000 | Shares | Sole | 2025-11-13 | |
| No filing history on record for this holder in this stock. | ||||||